Aarey Drugs & Pharmaceuticals Limited - Asset Resilience Ratio

Latest as of September 2025: 0.34%

Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) has an Asset Resilience Ratio of 0.34% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read AAREYDRUGS current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Rs9.99 Million

≈ $108.02K USD Cash + Short-term Investments

Total Assets

Rs2.94 Billion

≈ $31.79 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2013–2025)

This chart shows how Aarey Drugs & Pharmaceuticals Limited's Asset Resilience Ratio has changed over time. See Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Aarey Drugs & Pharmaceuticals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Aarey Drugs & Pharmaceuticals Limited market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs9.99 Million	0.34%
Total Liquid Assets	Rs9.99 Million	0.34%

Asset Resilience Insights

Limited Liquidity: Aarey Drugs & Pharmaceuticals Limited maintains only 0.34% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Aarey Drugs & Pharmaceuticals Limited Industry Peers by Asset Resilience Ratio

Compare Aarey Drugs & Pharmaceuticals Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	9.09%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.02%
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	Drug Manufacturers - Specialty & Generic	0.01%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%

Annual Asset Resilience Ratio for Aarey Drugs & Pharmaceuticals Limited (2013–2025)

The table below shows the annual Asset Resilience Ratio data for Aarey Drugs & Pharmaceuticals Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	0.74%	Rs17.56 Million ≈ $189.92K	Rs2.38 Billion ≈ $25.77 Million	+0.31pp
2024-03-31	0.43%	Rs12.95 Million ≈ $140.09K	Rs3.03 Billion ≈ $32.80 Million	+0.28pp
2023-03-31	0.14%	Rs4.18 Million ≈ $45.21K	Rs2.91 Billion ≈ $31.51 Million	-2.92pp
2022-03-31	3.06%	Rs75.07 Million ≈ $811.83K	Rs2.45 Billion ≈ $26.51 Million	+3.06pp
2021-03-31	0.01%	Rs129.95K ≈ $1.41K	Rs2.33 Billion ≈ $25.20 Million	0.00pp
2020-03-31	0.01%	Rs154.05K ≈ $1.67K	Rs1.94 Billion ≈ $20.99 Million	-0.01pp
2019-03-31	0.02%	Rs232.72K ≈ $2.52K	Rs1.46 Billion ≈ $15.76 Million	-1.67pp
2018-03-31	1.69%	Rs28.66 Million ≈ $309.95K	Rs1.70 Billion ≈ $18.36 Million	+1.39pp
2017-03-31	0.30%	Rs4.34 Million ≈ $46.91K	Rs1.43 Billion ≈ $15.49 Million	+0.27pp
2015-03-31	0.03%	Rs400.00K ≈ $4.33K	Rs1.15 Billion ≈ $12.43 Million	0.00pp
2014-03-31	0.04%	Rs400.00K ≈ $4.33K	Rs1.07 Billion ≈ $11.56 Million	+0.00pp
2013-03-31	0.04%	Rs400.00K ≈ $4.33K	Rs1.07 Billion ≈ $11.58 Million	--

pp = percentage points

About Aarey Drugs & Pharmaceuticals Limited

NSE:AAREYDRUGS India Drug Manufacturers - Specialty & Generic

Market Cap

$27.93 Million

Rs2.58 Billion INR

Market Cap Rank

#23936 Global

#1323 in India

Share Price

Rs91.08

Change (1 day)

+0.63%

52-Week Range

Rs50.16 - Rs99.25

All Time High

Rs99.25